MPL S505C enhances driver mutations at W515 in essential thrombocythemia.

Varghese, Leila N; Carreño-Tarragona, Gonzalo; Levy, Gabriel; Gutiérrez-López de Ocáriz, Xabier; Rapado, Inmaculada; Martínez-López, Joaquín; Ayala, Rosa; Constantinescu, Stefan

doi:10.1038/s41408-021-00583-4

MPL S505C enhances driver mutations at W515 in essential thrombocythemia.

Varghese, Leila N

;

Carreño-Tarragona, Gonzalo

;

Levy, Gabriel

;

Gutiérrez-López de Ocáriz, Xabier

;

Constantinescu, Stefan

;et.al.

(2021) Blood cancer journal — Vol. 11, n° 11, p. 188 (2021)

Files

126VargheseetalBloodcancerJ2021.pdf

Open Access
Adobe PDF
817.44 KB

Download

Details

Authors

Varghese, Leila N
Author
Carreño-Tarragona, Gonzalo
Author
Levy, GabrielUCLouvain
Author
Gutiérrez-López de Ocáriz, Xabier
Author
Constantinescu, StefanUCLouvain
Author

Affiliations

UCLouvainSSS/DDUV/SIGN - Cell signalling

Citations

APA
Chicago
FWB

Varghese, L. N., Carreño-Tarragona, G., Levy, G., Gutiérrez-López de Ocáriz, X., Rapado, I., Martínez-López, J., Ayala, R., & Constantinescu, S. (2021). MPL S505C enhances driver mutations at W515 in essential thrombocythemia. Blood cancer journal, 11(11), 188. https://doi.org/10.1038/s41408-021-00583-4 (Original work published 2021)